Sort
BiotechInvestor.com is a blog that provides daily biotech market updates, analysis, and education to the biotech investor. In parallel, we request that you step down as CEO or adjust your compensation to better align with the interests of shareholders. We also request that the company undergo additional restructuring to preserve cash during the sales process including closing offices outside of...
Rank
1
Vote
Sponsor
0.0
Hi. The Federal Reserve decided to not raise interest rates. This is big news and will benefit the stock market. So why the selloff? Cramer believes it’s profit taking from those who played the latest run up and it seems logical to me. I am not a huge fan of Cramer when it comes to individual stock investing but he knows his stuff when it comes to global economics. Here is a link to his talk...
Rank
2
Vote
Sponsor
0.0
BioInvest, publisher of the #1 ranked Medical Technology Stock Letter, offers stock analysis & research of emerging biotechnology companies to investors. MTSL Biotech Update - Anacor (ANAC) Buyout By Pfizer (PFE) Completes Biotech Rally Checklist #3 The News – This morning, Pfizer announced it...
Rank
3
Vote
Sponsor
0.0
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. As the world's largest biotechnology trade association, our members are leading the research and development of innovative healthcare,...
Rank
4
Vote
Sponsor
0.0
Biotech Insight publishes frequent news alerts regarding biotechnology companies, aimed specifically at investors. These alerts discuss recent developments in biotech, analysis of a given company's current and future products and any topical news or events. The editorial staff always seeks to...
Rank
5
Vote
Sponsor
0.0
After last week’s pessimistic post, this week I am focusing on potential catalysts in 2016 that could improve sentiment towards biotech as a sector. As if to remind us late stage trials don’t always fail, last week saw positive news from three different programs, all of which are antibodies in non-oncology indications. Regeneron (REGN) and its partner Sanofi (SNY) announced excellent data in...
Rank
6
Vote
Sponsor
0.0
We hope your visit will help you understand the opportunities and potential rewards that are available when you take a proactive approach to your personal financial situation. We have created this Web site to help you gain a better understanding of the financial concepts behind insurance, investing, retirement, estate planning, and wealth preservation. Most important, we hope you see the value...
Rank
7
Vote
Sponsor
0.0
Human Genome Sciences Inc. (NASDAQ: HGSI) is surging on reports that GlaxoSmithKline PLC (NYSE: GSK) could be set to make a $25.00 per share offer to acquire the company. The report surfaced in the Daily Mail out of the United Kingdom, and we would note that this publication pushes out enough rumors that it could be called the Daily Rumor (or Rumour for the Brits). It also has a spotty track...
Rank
8
Vote
Sponsor
0.0
Arguably more than any industry, biotechnology has the potential to impact the major issues facing the world today: health care, energy, food shortages, and climate change. Biotech Start is a resource for collating, sharing, and developing innovative ideas for turning scientific discoveries into world changing biotechnology startups. It was really painful to see promising bioentrepreneurs in...
Rank
9
Vote
Sponsor
0.0
Our team leverages its broad industry experience and truly understands the landscape at the intersection of healthcare and technology. We bring deep market knowledge and a broad network of pharma, venture capital and private equity relationships to help your company reach its next level of success. We consider it a privilege to work with clients on medical therapies & products that will greatly...
Rank
10
Vote
Sponsor
0.0
There are very few traders who have RevShark’s intuitive feel for the market. I especially appreciate Rev’s unique ability to recognize and utilize the distinct advantages of being a smaller, individual investor. Barry Ritholtz Founder and CIO , Ritholtz Wealth Management. RevShark helps you use your unique advantages as an individual investor, understand what is really moving the market on a...
Rank
11
Vote
Sponsor
0.0
Some reasons vary country by country. Germany, in particular, has lain fallow for many years in the aftermath of the dot-com boom. German tech stocks have come roaring back but there has not been a single biotech IPO on the Frankfurt exchange. Only one Germany biotech company, Affimed Therapeutics, an antibody therapeutics company in Heidelberg, had a NASDAQ IPO in 2013-14. It raised $56...
Rank
12
Vote
Sponsor
0.0
We work in partnership with clients to generate practical, economically viable and commercially successful product solutions and IP. We are an expanding team of highly trained R & D professionals focused on discovery and development of unique, natural compounds. We have successfully registered patents in the extraction of Azadirachtin, Allicin and Ajoene, and have further patents pending. We...
Rank
13
Vote
Sponsor
0.0
'I enjoyed myself at the conference and made some good contacts. Overall it was very worthwhile' Henry Rath, Amgen ‘The delegate mix worked well for us as a CRO’ Julie Wright Datatrial ‘Excellent – there were companies and investors that I don’t meet at other networking events’ Patricia Latter, London Bioscience Innovation Centre The 2015 conference is being held at the King's Fund conference...
Rank
14
Vote
Sponsor
0.0